Inogen (INGN) Minority Interest (2012 - 2013)

Inogen (INGN) reported Minority Interest of $118.7 million for Q4 2013, up 8.53% year-over-year from $109.3 million in Q4 2012, and up 5.98% quarter-over-quarter from $112.0 million in Q1 2013.

Inogen (INGN) Minority Interest (2012 - 2013) Analysis & Trends

Inogen (INGN) has 2 years of Minority Interest data on file, last reported at $118.7 million in Q4 2013.

  • Minority Interest for Q4 2013 came in at $118.7 million, up 8.53% year-over-year; the trailing twelve-month figure through Dec 2013 was $118.7 million (up 8.53% YoY), and the FY2013 annual result was $118.7 million, up 8.53% from the prior year.
  • Minority Interest advanced to $118.7 million in Q4 2013 per INGN's latest filing, from $112.0 million in the prior quarter.
  • Over five years, Minority Interest peaked at $118.7 million in Q4 2013 and troughed at $109.3 million in Q4 2012.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn
10 Inogen 176.23 Mn 81.82 Mn 37.86 Mn

Historic Data

Download Data
DateValue
Dec 31, 2013 118.67 Mn
Mar 31, 2013 111.98 Mn
Dec 31, 2012 109.35 Mn